Ablation by three-dimensional electroanatomical mapping versus anti-arrhythmic drug therapy: a cost-utility analysis in the treatment of idiopathic ventricular arrhythmias
The 3DEAM ablation strategy can be considered cost-utility intervention for treating IVAs in our region. These results are in line with published data on cost-effectiveness of 3DEAM ablations of IVA in developed countries.
Authors
- Tamara Jiménez Salcedo
- Carlos Jesus Toro-Huamanchumo (ORCID: https://orcid.org/0000-0002-4664-2856)
- Mario Cabrera-Saldaña (ORCID: https://orcid.org/0000-0001-9802-1376)
- Richard Soto-Becerra (ORCID: https://orcid.org/0000-0003-3447-061X)
- Diego Chambergo‐Michilot (ORCID: https://orcid.org/0000-0002-3904-7514)
- Pío Zelaya-Castro (ORCID: https://orcid.org/0000-0003-4455-4905)
- Daniel Fernandez‐Guzman (ORCID: https://orcid.org/0000-0002-9441-1067)
- José C. Navarro-Lévano
- Alejandro Jimenez-Restrepo
Institutions
- University of Maryland, Baltimore (US)
- National University of San Marcos (PE)
- Universidad Científica del Sur (PE)
- EsSALUD (PE)
- Florida Urology Associates (US)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1186/s12872-025-04683-y
- Citations
- 1
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39